Association of Chronic Obstructive Pulmonary Disease With Arrhythmia Risks: A Systematic Review and Meta-Analysis

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2021 Oct 18

PMID 34660734

Citations 5

Authors

Xin Liu

Zhuohui Chen

Siyuan Li

Shuo Xu

Affiliations

Soon will be listed here.

Abstract

A large number of studies have shown that the arrhythmia risks may be the potential causes of death among chronic obstructive pulmonary disease (COPD) patients. However, the association of COPD with risks of arrhythmias has never been systematically reviewed. Therefore, we performed a meta-analysis to assess the relationship between COPD and arrhythmia risks. An updated systematic retrieval was carried out within the databases of Embase and PubMed until June 27, 2021.The random-effects model was used to pool studies due to the potential heterogeneity across the included studies. The risk ratios (RRs) with 95% confidence intervals (CIs) were regarded as effect estimates. A total of 21 studies were included in our meta-analysis. In the pooled analysis by the random-effects model, the results showed that COPD was significantly related to the risk of atrial fibrillation (AF) (RR = 1.99, 95% CI: 1.46-2.70), ventricular arrhythmias (VA) (RR = 2.01, 95% CI: 1.42-2.85), and sudden cardiac death (SCD) (RR = 1.68, 95% CI: 1.28-2.21). The corresponding results were not changed after exclusion one study at a time. The pooled results were also stable when we re-performed the analysis using the fixed-effects model. Our current data suggested that COPD was associated with increased risks of AF, VA, and SCD.

Citing Articles

The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease.

Al-Jahdali H, Al-Lehebi R, Lababidi H, Alhejaili F, Habis Y, Alsowayan W Ann Thorac Med. 2025; 20(1):1-35.

PMID: 39926399 PMC: 11804957. DOI: 10.4103/atm.atm_155_24.

Types of Complications and Associated Factors in Patients Undergoing Permanent Cardiac Pacemaker Implantation: A Systematic Review.

Sugiharto F, Asmara A, Sari W, Freitas L, Ramdani D, Anna A J Multidiscip Healthc. 2025; 18():83-100.

PMID: 39822965 PMC: 11735829. DOI: 10.2147/JMDH.S489600.

Features of Atrial Fibrillation Pathogenesis and Prognosis in Chronic Obstructive Pulmonary Patients during the COVID-19 Pandemic.

Hazarapetyan L, Zelveian P, Grigoryan S Rev Cardiovasc Med. 2024; 24(2):51.

PMID: 39077394 PMC: 11273105. DOI: 10.31083/j.rcm2402051.

Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.

Singh D, Han M, Hawkins N, Hurst J, Kocks J, Skolnik N Adv Ther. 2024; 41(6):2151-2167.

PMID: 38664329 PMC: 11133105. DOI: 10.1007/s12325-024-02855-4.

Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure.

Bianco A, Canepa M, Catapano G, Marvisi M, Oliva F, Passantino A J Clin Med. 2024; 13(6).

PMID: 38541845 PMC: 10971568. DOI: 10.3390/jcm13061621.

References

Deng Y, Tong Y, Deng Y, Zou L, Li S, Chen H . Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2019; 8(14):e012540. PMC: 6662149. DOI: 10.1161/JAHA.119.012540. View

Al-Khatib S, Granger C, Huang Y, Lee K, Califf R, Simoons M . Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002; 106(3):309-12. DOI: 10.1161/01.cir.0000022692.49934.e3. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Rusnak J, Behnes M, Schupp T, Reiser L, Bollow A, Taton G . COPD increases cardiac mortality in patients presenting with ventricular tachyarrhythmias and aborted cardiac arrest. Respir Med. 2018; 145:153-160. DOI: 10.1016/j.rmed.2018.10.019. View

Kusunoki Y, Nakamura T, Hattori K, Motegi T, Ishii T, Gemma A . Atrial and Ventricular Arrhythmia-Associated Factors in Stable Patients with Chronic Obstructive Pulmonary Disease. Respiration. 2015; 91(1):34-42. DOI: 10.1159/000442447. View

Grymonprez M, Vakaet V, Kavousi M, Stricker B, Ikram M, Heeringa J . Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2018; 276:118-124. DOI: 10.1016/j.ijcard.2018.09.056. View

Wilchesky M, Ernst P, Brophy J, Platt R, Suissa S . Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest. 2012; 142(2):305-311. DOI: 10.1378/chest.11-1597. View

Desai R, Patel U, Singh S, Bhuva R, Fong H, Nunna P . The burden and impact of arrhythmia in chronic obstructive pulmonary disease: Insights from the National Inpatient Sample. Int J Cardiol. 2019; 281:49-55. DOI: 10.1016/j.ijcard.2019.01.074. View

Chahal H, Heckbert S, Barr R, Bluemke D, Jain A, Habibi M . Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study). Am J Cardiol. 2015; 115(12):1700-4. PMC: 4450133. DOI: 10.1016/j.amjcard.2015.03.018. View

10.

Lammers W, Kirchhof C, Bonke F, Allessie M . Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol. 1992; 262(1 Pt 2):H47-55. DOI: 10.1152/ajpheart.1992.262.1.H47. View

11.

Shepard Jr J, Garrison M, Grither D, Evans R, Schweitzer P . Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med. 1985; 78(1):28-34. DOI: 10.1016/0002-9343(85)90457-7. View

12.

Rusinowicz T, Zielonka T, Zycinska K . Cardiac Arrhythmias in Patients with Exacerbation of COPD. Adv Exp Med Biol. 2017; 1022:53-62. DOI: 10.1007/5584_2017_41. View

13.

Knuiman M, Briffa T, Divitini M, Chew D, Eikelboom J, McQuillan B . A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014; 29(3):181-90. DOI: 10.1007/s10654-013-9875-y. View

14.

Lip G, Skjoth F, Nielsen P, Larsen T . Evaluation of the CHEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study). Am J Cardiol. 2019; 125(1):48-54. DOI: 10.1016/j.amjcard.2019.09.034. View

15.

van den Berg M, Stricker B, Brusselle G, Lahousse L . Chronic obstructive pulmonary disease and sudden cardiac death: A systematic review. Trends Cardiovasc Med. 2016; 26(7):606-13. DOI: 10.1016/j.tcm.2016.04.001. View

16.

Konecny T, Park J, Somers K, Konecny D, Orban M, Soucek F . Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014; 114(2):272-7. DOI: 10.1016/j.amjcard.2014.04.030. View

17.

Li Y, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B . C HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study. J Am Heart Assoc. 2019; 8(13):e012546. PMC: 6662366. DOI: 10.1161/JAHA.119.012546. View

18.

Gorter T, van Melle J, Rienstra M, Borlaug B, Hummel Y, Van Gelder I . Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation. J Card Fail. 2017; 24(3):177-185. DOI: 10.1016/j.cardfail.2017.11.005. View

19.

Narayanan K, Reinier K, Uy-Evanado A, Teodorescu C, Zhang L, Chugh H . Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death. JACC Clin Electrophysiol. 2018; 1(5):381-387. DOI: 10.1016/j.jacep.2015.06.005. View

20.

Sidney S, Sorel M, Quesenberry Jr C, DeLuise C, Lanes S, Eisner M . COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4):2068-75. DOI: 10.1378/chest.128.4.2068. View